Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Adenocarcinoma
• Small Cell Lung Cancer

Drugs mentioned

• BL-B01D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Non Small Cell Lung Cancer, Lung Cancer | Phase 1 | Status: RECRUITING